Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Phytopharm initiates safety and tolerability study of PYM-50028 in PD

April 21, 2009

Forest and Cypress launch Savella for fibromyalgia

April 21, 2009

Impax provides clinical update on IPX-066 and IPX-056

April 21, 2009

Cannabinoid CB2 modulators claimed by Kalypsys as analgesics

April 21, 2009

PAION initiates phase Ib study of CNS-7056 in volunteers undergoing colonoscopy

April 20, 2009

Dainippon discontinues development of AC-3933 for dementia

April 20, 2009

GSK reports novel glycine transporter inhibitors for schizophrenia treatment

April 20, 2009

Copaxone approved by Health Canada for isolated syndrome suggestive of MS

April 17, 2009

Accera forms wholly owned subsidiary, Neuera Pharmaceuticals

April 16, 2009

XenoPort exercises co-promotion option contained in agreement with GSK for Solzira

April 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...